Obesity is one of the most common diseases in economically developed countries, leading to the development of type 2 diabetes mellitus and cardiovascular diseases. The central place in the treatment of obesity is occupied by property selected drug therapy. Evidence from this clinical case the efficacy of treatment for overweight and obese patients with a fixed combination of sibutramine and metformin is shown, which demonstrates the feasibility of using Reduxin forte as well as a logical pharmacotherapy option when canceling liraglutide.Funding. The study had no sponsor support. Conflict of interest. The authors declare no conflict of interest.